Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under ...
ThreatsDay Bulletin: active exploits, supply chain attacks, AI abuse, and stealth data risks observed this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results